No profile data available.
Merck & Co., Inc. (MRK) is a healthcare company in the additional cancer treatment drugs industry, based in Rahway, United States, with about 73,000 full-time employees.
It reported revenue of $65.01 billion for fiscal year 2025, up 1.3% from fiscal year 2024, and net income of $18.25 billion. In Q2 2026 (the quarter ended June 30, 2026) revenue was $16.61 billion, up 5.1% from a year before. Its largest business segment, Pharmaceutical, brought in 90% of segment revenue in fiscal year 2025; United States was the largest region with 56%. Its market capitalization was $359.22 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, Inc. operates as a healthcare company worldwide.
Merck & reported $65.01 billion in revenue for fiscal year 2025, up 1.3% from $64.17 billion in fiscal year 2024. In Q2 2026 revenue was $16.61 billion.
Pharmaceutical, with $58.14 billion or 90% of segment revenue in fiscal year 2025. Next: Animal Health (10%).
United States: 56% of revenue by region in fiscal year 2025, followed by Europe, Middle East and Africa (22%).
$359.22 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (additional cancer treatment drugs) include Bristol-Myers Squibb Company (BMY), Revolution Medicines, Inc. (RVMD), Exelixis, Inc. (EXEL), Summit Therapeutics Inc. (SMMT).